• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thiotepa-based autograft for primary central nervous system lymphoma.

作者信息

Baggio Diva, Cwynarski Kate

机构信息

Department of Haematology, University College Hospital, London.

出版信息

Haematologica. 2024 Oct 1;109(10):3083-3084. doi: 10.3324/haematol.2024.286132.

DOI:10.3324/haematol.2024.286132
PMID:39351694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11443386/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1f/11443386/f946391f0fdd/1093083.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1f/11443386/f946391f0fdd/1093083.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1f/11443386/f946391f0fdd/1093083.fig1.jpg

相似文献

1
Thiotepa-based autograft for primary central nervous system lymphoma.基于噻替派的自体移植物用于原发性中枢神经系统淋巴瘤
Haematologica. 2024 Oct 1;109(10):3083-3084. doi: 10.3324/haematol.2024.286132.
2
High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.原发性中枢神经系统淋巴瘤的大剂量化疗联合自体造血干细胞移植：来自日本造血细胞移植学会登记处的数据。
Biol Blood Marrow Transplant. 2019 May;25(5):899-905. doi: 10.1016/j.bbmt.2019.01.020. Epub 2019 Jan 18.
3
A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.使用噻替派、白消安和环磷酰胺预处理进行自体干细胞移植的中枢神经系统淋巴瘤患者毒性的综合评估
Biol Blood Marrow Transplant. 2017 Jan;23(1):38-43. doi: 10.1016/j.bbmt.2016.09.024. Epub 2016 Oct 3.
4
Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma.噻替派作为中枢神经系统淋巴瘤患者干细胞移植前预处理治疗的有效性和安全性。
Leuk Lymphoma. 2014 Dec;55(12):2712-20. doi: 10.3109/10428194.2014.889825. Epub 2014 Mar 26.
5
A Tale of Two Eras: The Story of Autologous Stem Cell Transplantation with and without Thiotepa for Primary Central Nervous System Lymphoma.两个时代的故事：原发性中枢神经系统淋巴瘤自体干细胞移植联合与不联合噻替派的故事
Biol Blood Marrow Transplant. 2019 May;25(5):e141-e142. doi: 10.1016/j.bbmt.2019.03.014. Epub 2019 Mar 14.
6
Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases.在复发或难治性原发性中枢神经系统淋巴瘤和眼内淋巴瘤中采用噻替派、白消安和环磷酰胺强化化疗和造血干细胞解救：79 例回顾性研究。
Haematologica. 2012 Nov;97(11):1751-6. doi: 10.3324/haematol.2011.060434. Epub 2012 May 11.
7
Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation.接受大剂量噻替派和白消安治疗后行自体干细胞移植的患者血小板恢复的继发性失败
Int J Hematol. 2020 Nov;112(5):609-613. doi: 10.1007/s12185-020-03007-4. Epub 2020 Sep 26.
8
Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant.采用基于大剂量白消安/噻替派的预处理方案及自体干细胞移植治疗继发性中枢神经系统淋巴瘤患者。
Leuk Lymphoma. 2016;57(1):28-33. doi: 10.3109/10428194.2015.1026901. Epub 2015 Mar 27.
9
Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.高剂量利妥昔单抗联合高剂量阿糖胞苷动员疗法及高剂量噻替派、白消安和环磷酰胺自体干细胞移植治疗非霍奇金淋巴瘤累及中枢神经系统患者的2期试验
Cancer. 2015 Jan 15;121(2):226-33. doi: 10.1002/cncr.29023. Epub 2014 Sep 9.
10
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.甲氨蝶呤、阿糖胞苷、噻替派和利妥昔单抗联合化疗免疫疗法（MATRix方案）用于原发性中枢神经系统淋巴瘤患者：国际结外淋巴瘤研究组-32（IELSG32）2期试验首次随机分组结果
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.

本文引用的文献

1
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.年龄较大、身体状况良好的原发性弥漫性大 B 细胞中枢神经系统淋巴瘤（MARTA）患者接受大剂量化疗和自体造血干细胞移植：一项单臂、2 期试验。
Lancet Haematol. 2024 Mar;11(3):e196-e205. doi: 10.1016/S2352-3026(23)00371-X. Epub 2024 Jan 29.
2
Primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤。
Nat Rev Dis Primers. 2023 Jun 15;9(1):29. doi: 10.1038/s41572-023-00439-0.
3
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
全脑放疗或自体干细胞移植作为原发性中枢神经系统淋巴瘤患者基于大剂量甲氨蝶呤的化疗免疫治疗后的巩固策略：国际结外淋巴瘤研究组-32二期试验第二次随机分组结果
Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.
4
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.22例难治性或复发性原发性中枢神经系统淋巴瘤或眼内淋巴瘤患者接受强化化疗后进行造血干细胞救援的结果。
J Clin Oncol. 2001 Feb 1;19(3):742-9. doi: 10.1200/JCO.2001.19.3.742.
5
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.一项针对11例眼内淋巴瘤患者的单中心研究，这些患者接受了传统化疗，其中5例随后接受了大剂量化疗和自体骨髓移植。
Leuk Lymphoma. 1996 Oct;23(3-4):339-45. doi: 10.3109/10428199609054837.